Abstract:BACKGROUND:Combretastatin A-4 (CA-4), which is an excellent antineoplastic agent, was isolated from Combretum caffrum. To date, structural modification studies of CA-4 have focused predominantly on the construction of new therapeutic agents for drug discovery. As a part of our ongoing work towards the modification of natural products, we have focused on the 3'-O-substituent groups in the B-ring of CA-4 under the hypothesis that these novel derivatives will possess good bioactivities and behave as effective antiproliferative pro-drugs.RESULTS:A series of novel CA-4 derivatives, which contained a 3'-O-substituted carbonic ether moiety, were synthesized and evaluated for their antitumor activities against four tumor cell lines, including MDA-MB-231, MCF-7, K562 and A549 cells. These derivatives exhibited clear antitumor activities, and CA-4E, in particular, showed the highest bioactivity of all of the derivatives tested against all four tumor cell lines, with IC50 values in the range of 1 to 180 nM. Based on its high bioactivity, CA-4E was subsequently selected to investigate the antitumor mechanism of these synthetic compounds. The cell cycle results demonstrated that CA-4E induced time- and dose-dependent G2/M arrest in a similar manner to CA-4, although its effect was more powerful than that of CA-4, and the apoptosis data showed that CA-4E induced cellular apoptosis in a dose-dependent manner.CONCLUSIONS:The newly synthesized CA-4 derivatives exhibited good antitumor activities in vitro, with CA-4E, in particular, showing the highest bioactivity of all of the compounds tested. Furthermore, CA-4E induced time- and dose-dependent G2/M arrest and cellular apoptosis in a dose-dependent manner. Taken together, these results suggest that CA-4E should be subjected to further investigation as a potential anticancer drug candidate.

4,5-Diaryl-3-Aminopyrazole Derivatives As Analogs Of Combretastatin A-4: Synthesis And Biological Evaluation

ChemInform Abstract: 4,5‐Diaryl‐3‐aminopyrazole Derivatives as Analogues of Combretastatin A‐4: Synthesis and Biological Evaluation.

Synthesis and Biological Evaluation of 3-Alkyl-1,5-Diaryl-1H-Pyrazoles as Rigid Analogues of Combretastatin A-4 with Potent Antiproliferative Activity

Synthesis And In Vitro Antitumor Activities Of 3,4-Diaryl Substituted Pyrrolones Derivatives

Synthesis andin vitroAntitumor Activities of 3,4-Diaryl Substituted Pyrrolones Derivatives

Synthesis and Biological Evaluations of 1,2‐Diaryl Pyrroles as Analogues of Combretastatin A‐4

Design, Synthesis, and Anticancer Activity Evaluation of Hybrids of Azoles and Barbituric Acids.

Synthesis and Biological Evaluation of Combretastatin A-4 Derivatives Containing a 3'-O-substituted Carbonic Ether Moiety As Potential Antitumor Agents.

Design and Synthesis of Cyclopropylamide Analogues of Combretastatin-A4 As Novel Microtubule-Stabilizing Agents

Development of Combretastatin A-4 Analogues as Potential Anticancer Agents with Improved Aqueous Solubility

Exploring Diverse-Ring Analogues on Combretastatin A4 (CA-4) Olefin As Microtubule-Targeting Agents

Design, Synthesis, and Anti-tumor Activity of Novel 2-Aryl Benzimidazole Compounds.

Design, Synthesis, And Biological Evaluation Of Hydantoin Bridged Analogues Of Combretastatin A-4 As Potential Anticancer Agents

Synthesis, biological evaluation and mechanism study of a class of cyclic combretastatin A-4 analogues as novel antitumour agents

Synthesis and mechanistic studies of novel spin-labeled combretastatin derivatives as potential antineoplastic agents.

Synthesis and biological evaluation of 2,3-diarylthiophene analogues of combretastatin A-4

4,5-Diaryl-1h-pyrrole-2-carboxylates As Combretastatin A-4/Lamellarin T Hybrids: Synthesis and Evaluation As Anti-Mitotic and Cytotoxic Agents

Design, Synthesis, Biological Evaluation and Cocrystal Structures with Tubulin of Chiral Β-Lactam Bridged Combretastatin A-4 Analogues As Potent Antitumor Agents.

Synthesis of Novel Spin-Labelled Combretastatin A-4 Derivatives As Potential Antineoplastic Agents

4,5-Diaryl-3h-1,2-dithiole-3-thiones and Related Compounds As Combretastatin A-4/oltipraz Hybrids: Synthesis, Molecular Modelling and Evaluation As Antiproliferative Agents and Inhibitors of Tubulin

Synthesis and In-Vitro Cytotoxicity of (E)-N,2,3-triarylacrylamide Derivatives As Analogs of Combretastatin A-4